# Impact of Topical Tranexamic Acid in Breast Reconstruction

> **NCT05807074** · PHASE4 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 23 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Tranexamic Acid
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT05807074
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-04-20
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05807074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05807074, "Impact of Topical Tranexamic Acid in Breast Reconstruction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05807074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*